Skip to main content
logo
PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
73.31
+2.46 (3.47%)
At close: Aug 7, 2026, 4:00 PM EDT
72.00
-1.31 (-1.79%)
After-hours: Aug 7, 2026, 7:34 PM EDT

PTC Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-38.38682.64-363.3-626.6-559.02-523.9
Depreciation & Amortization
55.338.8275.66236.59128.8464.13
Stock-Based Compensation
84.6674.5574.62101.64110.33103.51
Other Adjustments
-24.2-32.253.96134.5957.73122.01
Change in Receivables
-44.38-10.151.73-1.54-48.47-44.99
Changes in Inventories
-58.52-53.96.16-8.18-6.671.8
Changes in Accounts Payable
31.6671.74-33.3248.3527.5445.66
Changes in Unearned Revenue
-8.65-44.92-0.551.35-4.01
Changes in Other Operating Activities
-16.59-56.26121.25-42.08-68.69-22.55
Operating Cash Flow
-30.5711.2-107.69-158.42-356.65-251.33
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-9.28-8.86-6.5-28.44-32.02-28.21
Sale of Property, Plant & Equipment
-0.0728.06---
Purchases of Intangible Assets
-292.78-291.15-67.75-92.18-120.44-57.12
Proceeds from Sale of Intangible Assets
--150---
Purchases of Investments
-1,438-1,417-667.36-212.48-75.55-543.27
Proceeds from Sale of Investments
1,325855.12607.74156.37518.19847.78
Investing Cash Flow
-471.91-861.9844.18-176.74290.18219.18

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-240241.791,000300-
Long-Term Debt Repaid
----300-150-
Net Long-Term Debt Issued (Repaid)
-240241.79700150-
Issuance of Common Stock
102.1399.0533.7629.9971.0823.1
Net Common Stock Issued (Repurchased)
102.1399.0533.7629.9971.0823.1
Other Financing Activities
--7.95-1.49-101.79-53.13-2.22
Financing Cash Flow
536331.09255.87646.4167.9520.88

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.3322.71-7.333.11-2.77-7.82
Net Cash Flow
33.26203.02185.03314.3698.71-19.09

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-39.78702.34-114.19-186.86-388.67-279.55
Free Cash Flow Growth
------
FCF Margin
-3.94%40.58%-14.15%-19.92%-55.62%-51.90%
Free Cash Flow Per Share
-0.467.95-1.49-2.50-5.42-3.97
Levered Free Cash Flow
-44.46910.1946.67279.08-358.66-467.08
Unlevered Free Cash Flow
144.9837.09-134.54-189.93-375.37-321.64
SEC Filings: 10-K · 10-Q